STOCK TITAN

Pediatrix Medical Group Inc - MD STOCK NEWS

Welcome to our dedicated news page for Pediatrix Medical Group (Ticker: MD), a resource for investors and traders seeking the latest updates and insights on Pediatrix Medical Group.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Pediatrix Medical Group's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Pediatrix Medical Group's position in the market.

Rhea-AI Summary
Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Tuesday, May 7, 2024, at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2024. A detailed press release will be issued the morning of May 7, 2024, before the securities markets open.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Pediatrix Medical Group, Inc. (NYSE: MD) reported a loss from continuing operations of $1.50 per share for Q4 2023, with Adjusted EPS at $0.32. Net revenue was $496 million, while Adjusted EBITDA stood at $51 million. The company's operating plans for 2024 focus on reliable cash flow for future growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.93%
Tags
-
Rhea-AI Summary
Pediatrix Medical Group, Inc. to host top meetings in neonatal-perinatal medicine to address the high preterm birth rate in the U.S. The company's commitment to enhancing clinical expertise and improving outcomes highlighted through continuing education opportunities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.02%
Tags
conferences
Rhea-AI Summary
Pediatrix Medical Group, Inc. (MD) will host an investor conference call and webcast to discuss Q4 2023 results. The detailed press release will be issued on February 20, 2024, before the securities markets open. The webcast will be accessible on Pediatrix's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.31%
Tags
none
-
Rhea-AI Summary
Miller Children's & Women's Hospital Long Beach Announces Creation of Neonatal Network
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.39%
Tags
partnership
-
Rhea-AI Summary
Pediatrix Medical Group, Inc. reported earnings of $0.26 per share for Q3 2023, with net revenue of $507 million and adjusted EBITDA of $50 million. The company faced challenges with soft patient volumes and cost growth. They plan to enhance operating effectiveness and generate a stable gross-margin profile. Pediatrix terminated its services agreement with R1 RCM and will utilize a hybrid revenue cycle management function.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.78%
Tags
Rhea-AI Summary
Pediatrix Medical Group to host investor conference call and webcast on November 2, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.94%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.66%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.47%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.15%
Tags
management
Pediatrix Medical Group Inc

NYSE:MD

MD Rankings

MD Stock Data

776.40M
81.66M
1.38%
103.02%
4.9%
General Medical and Surgical Hospitals
Health Care and Social Assistance
Link
United States
Sunrise

About MD

mednax is a physician-led health solutions partner providing the highest quality patient care through our national network of nearly 3,000 physicians. our physician practices and business professionals are passionate about taking great care of patients, continually optimizing performance and helping providers overcome healthcare’s quality, financial and administrative complexities. physicians and advanced practitioners practicing as part of mednax are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research to enhance patient outcomes and provide high-quality, cost-effective care. the company was founded in 1979, and today, through its affiliated professional corporations, mednax provides services through a network of more than 3,200 physicians in all 50 states and puerto rico. in addition to its national physician network, mednax provides services to healthcare facilities and physicians in